91精品乱码久久蜜桃麻豆,www.17c.com国产大片,寡妇高潮一级毛片免费看,久久人妻少妇嫩草av
d3-pcbanner-33.jpg d3-phbanner.jpg
Clinical Trials
A Randomized, Single blind, Placebo Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of Subcutaneously Administered RBD4059 in Healthy Subjects

“A Randomized, Single-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of Subcutaneously Administered RBD5044 in Healthy Subjects”, this study is ongoing in Australia. the study is currently in the single-dose incremental enrolment phase.

Learn More
A Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of Subcutaneously Administered RBD5044 in Healthy Subjects

“A Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of Subcutaneously Administered RBD5044 in Healthy Subjects”, this study is ongoing in Australia. The study has completed enrolment in the single dose-escalation phase, and is currently in the multiple dose-escalation enrolment phase.

Learn More
A single and repeated dose escalation study to evaluate the safety, tolerability, pharmacokinetics and preliminary pharmacodynamics of RBD7022 in subjects with normal or elevated LDL cholesterol

“A randomized, single-blind, placebo-controlled, single-center, single-dose-escalation, and multi-dose-escalation phase I trial evaluated the safety, tolerability, pharmacokinetic, and preliminary pharmacodynamic characteristics of subcutaneous RBD7022 in subjects with normal or elevated LDL cholesterol” is ongoing.

Learn More
A single and repeated dose escalation study to evaluate the safety, pharmacokinetics and preliminary pharmacodynamics of RBD1016 in subjects with chronic hepatitis B virus (HBV) infection

" A Single and Repeated Dose Escalation, Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics and Preliminary Pharmacodynamics of?RBD1016?in Subjects With Chronic Hepatitis B Virus (HBV) Infection“, has been Completed in Hong Kong, China.

Learn More
A clinical trial to evaluate the safety and pharmacokinetics of RBD1016 in healthy subjects

“A randomized, double-blind, placebo-controlled, single-dose escalation phase Ia clinical Study to evaluate the safety and pharmacokinetics of RBD1016 in healthy subjects” has been completed in Australia.

Learn More